Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Antiviral Res. 2020 Aug 10;182:104904. doi: 10.1016/j.antiviral.2020.104904

Figure 4.

Figure 4.

Favipiravir (T-705) effectively reduces footpad swelling in CHIKV-infected mice at doses of 400 mg/kg/d (A-E), while it is less effective at a dose of 100 mg/kg/d (F-J). There appeared to be equivalent efficacy in mice infected with LR06, SEN, or NGR. Footpad swelling (A-C, F-H), viremia (D, I) and virus titer in the hind limb on 6 dpi (E, J) were used as disease parameters (***P<0.001, **P<0.01, *P<0.05 as compared with virus infection controls).